With a robust background in healthcare investments, the fund manager has successfully executed over 30 deals across North America and Europe. Emphasizing a data-driven strategy, they have built a diverse portfolio that spans early-stage to growth equity investments. Their expertise includes notable exits in biotech and medical devices, showcasing a strong thematic focus on innovation within the sector. Leveraging an operator-first approach, they prioritize operational improvements to drive value creation in their portfolio companies.